Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Armstrong TS"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 49
Tytuł:
Clinical outcome assessment trends in clinical trials-Contrasting oncology and non-oncology trials.
Autorzy:
Kim Y; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Aug; Vol. 12 (16), pp. 16945-16957. Date of Electronic Publication: 2023 Jul 08.
Typ publikacji:
Journal Article; Research Support, N.I.H., Intramural
MeSH Terms:
Neoplasms*/therapy
Humans ; Medical Oncology ; Outcome Assessment, Health Care ; Research Design ; Clinical Trials as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Feasibility and preliminary efficacy of a virtual reality intervention targeting distress and anxiety in primary brain tumor patients at the time of clinical evaluation: Study protocol for a phase 2 clinical trial.
Autorzy:
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. .
Acquaye-Mallory AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Mendoza T; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Stockdill ML; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
Pokaż więcej
Źródło:
BMC cancer [BMC Cancer] 2023 Mar 21; Vol. 23 (1), pp. 262. Date of Electronic Publication: 2023 Mar 21.
Typ publikacji:
Clinical Trial Protocol; Journal Article
MeSH Terms:
Virtual Reality Exposure Therapy*/methods
Brain Neoplasms*/therapy
Humans ; Feasibility Studies ; Anxiety/etiology ; Anxiety/therapy ; Anxiety Disorders ; Randomized Controlled Trials as Topic ; Multicenter Studies as Topic ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Multifactorial Model of Cancer-Related Cognitive Impairment.
Autorzy:
Oppegaard KR; University of California, San Francisco.
Mayo SJ; University of Toronto.
Armstrong TS; National Institutes of Health.
Anguera JA; University of California, San Francisco.
Kober KM; University of California, San Francisco.
Miaskowski C; University of California, San Francisco.
Pokaż więcej
Źródło:
Oncology nursing forum [Oncol Nurs Forum] 2023 Feb 17; Vol. 50 (2), pp. 135-147.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:
Cognitive Dysfunction*/etiology
Neoplasms*/complications
Humans ; Research Personnel ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The link between psychological distress and survival in solid tumor patients: A systematic review.
Autorzy:
Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Cooper D; National Institutes of Health Library, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2023 Feb; Vol. 12 (3), pp. 3343-3364. Date of Electronic Publication: 2023 Jan 05.
Typ publikacji:
Systematic Review; Journal Article; Review; Research Support, N.I.H., Intramural
MeSH Terms:
Neoplasms*
Psychological Distress*
Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Histological analysis of sleep and circadian brain circuitry in cranial radiation-induced hypersomnolence (C-RIH) mouse model.
Autorzy:
Shuboni-Mulligan DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. .
Young D Jr; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
De La Cruz Minyety J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Munasinghe J; Mouse Imaging Facility, National Institute of Neurological Disorder and Stroke, NIH, Bethesda, MD, USA.
Wang H; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Adegbesan KA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Smart DK; Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jul 01; Vol. 12 (1), pp. 11131. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:
Circadian Rhythm*/physiology
Disorders of Excessive Somnolence*
Animals ; Brain ; Disease Models, Animal ; Mice ; Sleep/physiology ; Suprachiasmatic Nucleus/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Exploring the prevalence and burden of sleep disturbance in primary brain tumor patients.
Autorzy:
King AL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Shuboni-Mulligan DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Crandon S; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye AA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boris L; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Christ A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Jammula V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Theeler B; Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Wall K; Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, Maryland, USA.
Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Jun 22; Vol. 9 (6), pp. 526-535. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments.
Autorzy:
Jammula V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Rogers JL; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Christ A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leeper HE; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choi A; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grajkowska E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Levine JE; Office of Information Technology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lindsley M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Reyes J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Roche KN; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Timmer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boris L; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Burton E; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Lollo N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Panzer M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Smith-Cohn MA; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Penas-Prado M; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pillai V; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Theeler BJ; Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA.
Wu J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 May 14; Vol. 9 (5), pp. 429-440. Date of Electronic Publication: 2022 May 14 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Assessing mobility in primary brain tumor patients: A descriptive feasibility study using two established mobility tests.
Autorzy:
Rogers JL; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
De La Cruz Minyety J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye AA; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Payén SS; Center for Nursing Research, Cizik School of Nursing, The University of Texas Health Science Center at Houston, Houston, Texas, USA.
Weinberg JS; Department of Neurosurgery, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Weathers SS; Department of Neuro-Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2022 Feb 17; Vol. 9 (3), pp. 219-228. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Tumor Mutation Burden, Expressed Neoantigens and the Immune Microenvironment in Diffuse Gliomas.
Autorzy:
Yu G; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pang Y; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Merchant M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kesserwan C; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Gangalapudi V; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Abdelmaksoud A; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Ranjan A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kim O; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Wei JS; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Chou HC; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Wen X; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Sindiri S; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Song YK; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Xi L; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Kaplan RN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Aldape K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Khan J; Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Wu J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Dec 03; Vol. 13 (23). Date of Electronic Publication: 2021 Dec 03.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of Circadian Clock Gene Expression with Glioma Tumor Microenvironment and Patient Survival.
Autorzy:
De La Cruz Minyety J; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Shuboni-Mulligan DD; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Briceno N; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Young D Jr; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Gilbert MR; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Celiku O; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Armstrong TS; Neuro-Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD 20814, USA.
Pokaż więcej
Źródło:
Cancers [Cancers (Basel)] 2021 Jun 02; Vol. 13 (11). Date of Electronic Publication: 2021 Jun 02.
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Living with a central nervous system (CNS) tumor: findings on long-term survivorship from the NIH Natural History Study.
Autorzy:
Rogers JL; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Vera E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Acquaye A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Briceno N; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Jammula V; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
King AL; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leeper H; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Quezado MM; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gonzalez Alarcon J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Boris L; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, Maryland, USA.
Burton E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Celiku O; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Choi A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Christ A; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Crandon S; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Grajkowska E; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Leggiero N; Concentric Methods, LLC, Manassas, Virginia.
Lollo N; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Penas-Prado M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Reyes J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Siegel C; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, Maryland, USA.
Theeler BJ; Department of Neurology, Walter Reed National Military Medical Center, Bethesda, Maryland, USA.
Timmer M; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Wall K; Leidos Biomedical Research, Frederick National Laboratory for Cancer Research Sponsored by the National Cancer Institute, Frederick, Maryland, USA.
Wu J; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Aldape K; Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2021 Apr 10; Vol. 8 (4), pp. 460-474. Date of Electronic Publication: 2021 Apr 10 (Print Publication: 2021).
Typ publikacji:
Journal Article
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative.
Autorzy:
Dirven L; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands.
Vos ME; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.
Walbert T; Department of Neurology and Neurosurgery, Henry Ford Health System, Detroit, Michigan, USA.
Armstrong TS; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.
Arons D; National Brain Tumor Society, Newton, Massachusetts, USA.
van den Bent MJ; Department of Neurology, Erasmus Medical Center Cancer Institute, Rotterdam, the Netherlands.
Blakeley J; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Brown PD; Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Bulbeck H; Brainstrust - The Brain Cancer People, Cowes, Isle of Wight, UK.
Chang SM; Division of Neuro-Oncology, University of California San Francisco, San Francisco, California, USA.
Coens C; Statistical Department, European Organization for Research and Treatment of Cancer Headquarters, Brussels, Belgium.
Gilbert MR; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.
Grant R; Department of Clinical Neurosciences, Royal Infirmary of Edinburgh, Edinburgh, UK.
Jalali R; Neuro-Oncology Disease Management Group, Tata Memorial Centre, Mumbai, Maharashtra, India.
Leach D; National Brain Tumor Society, Newton, Massachusetts, USA.
Leeper H; Neuro-Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institute of Health, Bethesda, Maryland, USA.
Mendoza T; Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Nayak L; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Oliver K; International Brain Tumour Alliance, Tadworth, Surrey, UK.
Reijneveld JC; Department of Neurology and Brain Tumor Center Amsterdam, Amsterdam University Medical Centers (location VUmc), Amsterdam, the Netherlands.; Stichting Epilepsie Instellingen Nederland (SEIN), Heemstede, the Netherlands.
Le Rhun E; Departments of Neurosurgery, Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
Rubinstein L; Biometric Research Program, National Cancer Institute, Bethesda, Maryland, USA.
Weller M; Department of Neurology and Brain Tumor Center, University Hospital and University of Zurich, Zurich, Switzerland.
Wen PY; Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Taphoorn MJB; Department of Neurology, Leiden University Medical Center, Leiden, the Netherlands.; Department of Neurology, Haaglanden Medical Center, The Hague, the Netherlands.
Pokaż więcej
Źródło:
Neuro-oncology practice [Neurooncol Pract] 2021 Feb 13; Vol. 8 (4), pp. 417-425. Date of Electronic Publication: 2021 Feb 13 (Print Publication: 2021).
Typ publikacji:
Journal Article; Review
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Wyświetlanie 1-20 z 49

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies